{
  "context": {
    "rules": [
      "Rule1: If the experimental drug demonstrates safety in human subjects, then the experimental drug demonstrates efficacy against the target disease",
      "Rule2: If the clinical trial meets sample size requirements for statistical validity, then the clinical trial achieves sufficient power in statistical analysis",
      "Rule3: The clinical trial meets sample size requirements for statistical validity or the clinical trial maintains compliance with ethical standards",
      "Rule4: If the clinical trial maintains compliance with ethical standards, then the experimental drug demonstrates safety in human subjects",
      "Rule5: If the clinical trial achieves sufficient power in statistical analysis, then the clinical trial shows statistical significance for the primary endpoint",
      "Rule6: The research institution secures funding through a government grant or the research institution secures funding through private investment",
      "Rule7: If the research institution secures funding through private investment, then the clinical trial receives regulatory approval from the European Union or the clinical trial receives regulatory approval from the Global Health Organization",
      "Rule8: The clinical trial faces regulatory challenges from local authorities or if the research institution secures funding through a government grant, then the clinical trial receives regulatory approval from the European Union or the clinical trial receives regulatory approval from the Global Health Organization",
      "Rule9: The clinical trial receives regulatory approval from the United States or the clinical trial receives regulatory approval from the European Union or the clinical trial receives regulatory approval from the Global Health Organization",
      "Rule10: The clinical trial completes Phase III or the clinical trial completes Phase II",
      "Rule11: If the clinical trial completes Phase II, then the clinical trial receives regulatory approval from China or the clinical trial receives regulatory approval from the Global Health Organization",
      "Rule12: If the research team publishes results of the clinical trial, then if the clinical trial completes Phase III, then the clinical trial receives regulatory approval from China or the clinical trial receives regulatory approval from the Global Health Organization",
      "Rule13: The research team publishes results of the clinical trial or the research team submits documentation to regulatory bodies",
      "Rule14: If the research team submits documentation to regulatory bodies, then the medical journal peer reviews the clinical trial",
      "Rule15: If the medical journal peer reviews the clinical trial, then if the clinical trial completes Phase III, then the clinical trial receives regulatory approval from China or the clinical trial receives regulatory approval from the Global Health Organization",
      "Rule16: If the experimental drug demonstrates efficacy against the target disease, then the clinical trial receives regulatory approval from the Global Health Organization"
    ],
    "facts": [
      "Fact1: The clinical trial does not receive regulatory approval from the European Union",
      "Fact2: The clinical trial does not show statistical significance for the primary endpoint",
      "Fact3: The clinical trial does not face regulatory challenges from local authorities",
      "Fact4: The clinical trial does not receive regulatory approval from the United States",
      "Fact5: The clinical trial does not receive regulatory approval from China"
    ]
  },
  "question": "The clinical trial receives regulatory approval from the Global Health Organization"
}